文献速递呼吸道感染呼吸危重症与机械通气

重症肺炎患者肺孢子菌定植的临床特征与预后:多中心回顾性研究

Clinical Characteristics and Prognosis of Patients With Severe Pneumonia With Pneumocystis jirovecii Colonization: A Multicenter, Retrospective Study.
PubMed 文献 · Chest · 2024-07-23

该多中心回顾性匹配研究纳入2019至2023年17个ICU中接受支气管肺泡灌洗临床宏基因组检测的重症肺炎患者,比较肺孢子菌定植者与阴性者的临床特征和预后。结果显示免疫抑制和淋巴细胞降低是定植的危险因素,定植组肺部病毒检出更频繁,且定植是重症肺炎患者死亡的独立危险因素,与28天死亡率升高相关。

要点

  • 重症肺炎中肺孢子菌阳性者约40%为定植,定植与免疫抑制和淋巴细胞降低相关。
  • 肺孢子菌定植组肺部巨细胞病毒等病毒检出更频繁。
  • 肺孢子菌定植是重症肺炎患者死亡的独立危险因素,与28天死亡率升高相关。

核心结论

  • 肺孢子菌定植是重症肺炎患者死亡的独立危险因素,与28天死亡率升高相关。
  • 免疫抑制和淋巴细胞计数降低是非肺孢子菌肺炎患者肺孢子菌定植的危险因素。

研究设计与样本

  • 多中心、回顾性、匹配研究,纳入2019至2023年17个医疗中心ICU中接受支气管肺泡灌洗临床宏基因组检测的重症肺炎患者。
  • 采用倾向性评分匹配和Cox多因素回归分析比较肺孢子菌定植者与阴性者的预后。

主要发现

  • 肺孢子菌阳性患者中40%被认为存在肺孢子菌定植。
  • 定植组免疫抑制患者比例更高、淋巴细胞计数更低。
  • 定植组肺部巨细胞病毒、EB病毒、人类疱疹病毒6B、人类疱疹病毒7和细环病毒检出更频繁。
  • Cox比例风险模型显示肺孢子菌定植是重症肺炎患者死亡的独立危险因素。
  • 敏感性分析(纳入或排除共检出微生物、未接受甲氧苄啶-磺胺甲噁唑治疗患者)得到相似结论。

关键数值与推荐

  • 肺孢子菌阳性患者中40%考虑为定植。
  • 肺孢子菌定植与重症肺炎患者28天死亡率升高相关。

临床怎么用

  • 对重症肺炎患者,尤其免疫抑制和淋巴细胞降低者,应关注肺孢子菌定植及共检出病毒。
  • 肺孢子菌定植可能提示预后不良,需加强病情评估与随访。

局限性

  • 回顾性研究设计。
  • 定植诊断基于临床宏基因组、肺部CT和临床表现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For decades, the incidence and clinical characteristics of Pneumocystis jirovecii colonization in patients with severe pneumonia was unclear. RESEARCH QUESTION: What are the clinical features and outcomes associated with P jirovecii colonization in individuals diagnosed with severe pneumonia? STUDY DESIGN AND METHODS: In this multicenter, retrospective, matched study, patients with severe pneumonia who underwent bronchoalveolar lavage clinical metagenomics from 2019 to 2023 in the ICUs of 17 medical centers were enrolled. Patients were diagnosed based on clinical metagenomics, pulmonary CT scans, and clinical presentations. Clinical data were collected retrospectively, and according to propensity score matching and Cox multivariate regression analysis, the prognosis of patients with P jirovecii colonization was compared with that of patients who were P jirovecii-negative. RESULTS: A total of 40% of P jirovecii-positive patients are considered to have P jirovecii colonization. The P jirovecii colonization group had a higher proportion of patients with immunosuppression and a lower lymphocyte count than the P jirovecii-negative group. More frequent detection of cytomegalovirus, Epstein-Barr virus, human herpesvirus-6B, human herpesvirus-7, and torque teno virus in the lungs was associated with P jirovecii colonization than with P jirovecii negativity. By constructing two cohorts through propensity score matching, we incorporated codetected microorganisms and clinical features into a Cox proportional hazards model and revealed that P jirovecii colonization was an independent risk factor for mortality in patients with severe pneumonia. According to sensitivity analyses, which included or excluded codetected microorganisms, and patients not receiving trimethoprim-sulfamethoxazole treatment, similar conclusions were reached. INTERPRETATION: Immunosuppression and a reduced lymphocyte count were identified as risk factors for P jirovecii colonization in patients with non-Pneumocystis pneumonia. More frequent detection of various viruses was observed in patients colonized with P jirovecii, and P jirovecii colonization was associated with an increased 28-day mortality in patients with severe pneumonia.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Jiang Y, Huang X, Zhou H, et al. Clinical Characteristics and Prognosis of Patients With Severe Pneumonia With Pneumocystis jirovecii Colonization: A Multicenter, Retrospective Study. Chest. 2024. PMID: 39053646. doi:10.1016/j.chest.2024.07.140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。